Gerstenfeld's 2003 Prospect Article frames fracture healing as a recapitulation of embryological skeletal development occurring in a unique postnatal environment. It systematically reviews the anatomy of the fracture callus, the origins of skeletogenic stem cells, the biomechanical determinants of tissue differentiation, and the temporal molecular biology of three key soluble factor groups. The paper synthesizes data from the authors' own murine fracture models alongside the broader literature to build a unified framework for how bone repairs itself.
Every decision you make at the fracture table has a molecular consequence — this paper is the map.
When you strip periosteum to get a reduction, you remove the primary stem cell reservoir for callus formation. When you choose flexible vs. Rigid fixation, you are choosing between a cartilage-mediated and a direct ossification pathway: shear and bending commit progenitors to chondrocytes, stability permits direct osteoblast differentiation.
When a patient asks about NSAIDs after fracture, the TNF-α data here provides the mechanism: inflammatory cytokines are required initiators of the repair cascade, not collateral damage. Blocking COX-2 (referenced in Gerstenfeld et al., 2003 in press) and suppressing TNF both impair the early inflammatory phase that sets up symmetric callus.
The BMP temporal windows ground the clinical logic behind exogenous BMP-2 delivery: its endogenous peak is day 1, and the late-phase BMPs (3, 4, 7, 8) coordinate cartilage resorption at days 14–21. Placing a scaffold too early or too late relative to these windows may explain inconsistent results seen with BMP augmentation in clinical trials.
Gerstenfeld's 2003 Prospect Article frames fracture healing as a recapitulation of embryological skeletal development occurring in a unique postnatal environment. It systematically reviews the anatomy of the fracture callus, the origins of skeletogenic stem cells, the biomechanical determinants of tissue differentiation, and the temporal molecular biology of three key soluble factor groups. The paper synthesizes data from the authors' own murine fracture models alongside the broader literature to build a unified framework for how bone repairs itself.
Every decision you make at the fracture table has a molecular consequence — this paper is the map.
When you strip periosteum to get a reduction, you remove the primary stem cell reservoir for callus formation. When you choose flexible vs. Rigid fixation, you are choosing between a cartilage-mediated and a direct ossification pathway: shear and bending commit progenitors to chondrocytes, stability permits direct osteoblast differentiation.
When a patient asks about NSAIDs after fracture, the TNF-α data here provides the mechanism: inflammatory cytokines are required initiators of the repair cascade, not collateral damage. Blocking COX-2 (referenced in Gerstenfeld et al., 2003 in press) and suppressing TNF both impair the early inflammatory phase that sets up symmetric callus.
The BMP temporal windows ground the clinical logic behind exogenous BMP-2 delivery: its endogenous peak is day 1, and the late-phase BMPs (3, 4, 7, 8) coordinate cartilage resorption at days 14–21. Placing a scaffold too early or too late relative to these windows may explain inconsistent results seen with BMP augmentation in clinical trials.